Leading Innovation in the Life Sciences
New York Bio Connect aims to simplify and amplify the state and city’s life sciences ecosystem, organizing opportunities from Manhattan to Buffalo to position students, entrepreneurs, investors, policy makers, and established industry leaders for success.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
NewYorkBIO and Life Sciences Cares New York Announce Strategic Relationship
NewYorkBIO, the leading advocate of New York’s life science community, and Life Science Cares today announced a strategic relationship to advance both the growth of New York’s life science ecosystem and support underserved communities across the state. Through this collaboration, the two organizations will mobilize the life science sector to drive community impact – connecting…
Empire State Development Announces Weill Cornell Medicine And University At Albany As Recipients Of New York Global Entrepreneurs Program Grants
Empire State Development (ESD) announced Weill Cornell Medicine and the University at Albany as the inaugural grant recipients for the New York Global Entrepreneurs Program (NYGEP). Administered by ESD’s Division of Science, Technology & Innovation (NYSTAR), the program aims to attract and retain the most promising international founders launching innovative startups in New York instead…
Empire State Development Awards $400,000 To Help Four New York Businesses Commercialize Cutting-Edge Technologies
Empire State Development awarded $400,000 through Round 5 of NYSTAR’s Innovation Matching Grants program to four New York City businesses including MilkShaker Inc. (biotech/wearables). The grants match federal SBIR/STTR awards, covering commercialization costs like marketing and legal support that federal funding excludes. NYSTAR’s broader network of innovation programs generates nearly $3 billion in annual economic…
New York Biotech Industry is on the Rise
Adam Volini, executive director and VP of Life Science & Strategic Partnerships at Empire State Development shares New York’s ambitious future and how the state is emerging as a competitive US biotech hub.
Ognomy Sleep Raises $20M Series A to Expand Virtual Sleep Apnea Care
Ognomy Sleep, a leading virtual sleep medicine platform transforming access to diagnosis and treatment for obstructive sleep apnea, announced the closing of a $20 million Series A financing round led by Catalyst Investors, with participation from Blue Heron Capital. The round also included new and follow-on investments from Impellent Ventures, LaunchNY, Excell and Upstate Biotech…
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
#2
NATIONAL R&D SPEND
100,000+
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.